FDA approves generic versions of controversial OxyContin

OxyContin may now go generic, U.S. regulators have ruled, but only if Teva Pharmaceuticals and Endo Pharmaceutical Holdings, whose products were approved, take steps to prevent illegal use of the drug. OxyContin, a strong opioid painkiller, is made by Purdue Pharma, which instigated procedures to prevent abuse by users who crushed the pill and took it all at once to get a high instead of allowing it to be dispensed by a time-release method, as intended.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC